[Treatment of neoplastic thromboses of the inferior vena cava secondary to adenocarcinomas of the kidney. Study of 40 cases].
The extension of renal cell cancer into the vena cava is not inaccessible to treatment. In the absence of any other effective treatment, only surgical resection is able to provide a chance of long term survival. The authors report their experience of 40 cases, 24 of which underwent complete resection of their lesions. The survival rates in these cases were 47.6% at 1 year, 28.6% at 2 years, 15% at 3 years and 9.5% at 5 and 7 years. A selective approach to the right auricle was performed in three patients and the technique of this operation is outlined. The global mortality was 8.8%. The various technical possibilities and the prognostic factors are also reviewed.
D000230:Adenocarcinoma / Q000473:pathology*; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009360:Neoplastic Cells, Circulating; D014682:Vena Cava, Inferior / Q000473:pathology / Q000601:surgery*
Le traitement des thromboses néoplasiques de la veine cave inférieure secondaires aux adénocarcinomes du rein. Etude de quarante cas.